Inventor · disambiguated record
Patrick Reeves
Also filed as: REEVES PATRICK · REEVES PATRICK M · REEVES PATRICK MICHAEL
3 granted patents·10 pending applications·4 citations·filing 2010–2022
56Inventor score
Files withMASSACHUSETTS GEN HOSPITAL10APERISYS INC1KALMAN DANIEL1THE GENERAL HOSPITAL CORP D/B/A MASSACHUSETTS GENERAL HOSPITAL1
Top patents by PatentIndex Score
13 records- 0181US11305017B2Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Apr 19, 2022·1 cites·16 claims
- 0277US8765777B2Compositions and methods of use for tyrosine kinase inhibitors to treat pathogenic infectionKALMAN DANIEL·Filed 2010·Granted Jul 1, 2014·3 cites·18 claims
- 0369US2022226474A1Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2022·Application pending·0 cites
- 0463US2025124570A1Methods for identifying cross-modal features from spatially resolved data setsMASSACHUSETTS GEN HOSPITAL·Filed 2022·Application pending·0 cites
- 0561US2023306761A1Methods for identifying cross-modal features from spatially resolved data setsMASSACHUSETTS GEN HOSPITAL·Filed 2021·Application pending·0 cites
- 0656US11419894B2Modified natural killer cells for the treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Aug 23, 2022·0 cites·20 claims
- 0751US2018117155A1Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2016·Application pending·0 cites
- 0845US2020093789A1Cancer Treatment with a CXCL12 Signaling Inhibitor and an Immune Checkpoint InhibitorMASSACHUSETTS GEN HOSPITAL·Filed 2018·Application pending·0 cites
- 0942US2019133998A1Treatment of tumors with inhibitors of cxcl12 signaling and subtherapeutic amounts of chemotherapeutic agentsMASSACHUSETTS GEN HOSPITAL·Filed 2017·Application pending·0 cites
- 1039US2018117006A1Anti-fugetactic agent and immunotherapy agent combination therapy and compositions for the treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2016·Application pending·0 cites
- 1137US2018325953A1Modified immune cells and uses thereofAPERISYS INC·Filed 2016·Application pending·0 cites
- 1234US2018353472A1Unit dose formulations for use as an anti-fugetactic agentTHE GENERAL HOSPITAL CORP D B A MASSACHUSETTS GENERAL HOSPITAL·Filed 2016·Application pending·0 cites
- 1334US2018117005A1Compositions for the treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrick Reeves files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →